Nikhil Rammohan (@nikhil_rm_mdphd) 's Twitter Profile
Nikhil Rammohan

@nikhil_rm_mdphd

Assistant Professor @WashURadOnc, H&N, CNS, Imaging researcher

ID: 1158528889

calendar_today07-02-2013 23:12:05

95 Tweet

144 Followers

338 Following

Benjamin Rich (@benrichmd) 's Twitter Profile Photo

RTOG 0815 now out in JCO. Dose-escalated RT for intermediate risk prostate cancer w/wo short-term ADT. Median follow-up 6.3 years. ADT reduced PSA failure, DM, PCSM, salvage therapy use. No OS benefit, but unlikely with ~6 years FU. #radonc #pcsm ascopubs.org/doi/10.1200/JC…

C. Jillian Tsai, MD, PhD (@cjtsaimdphd) 's Twitter Profile Photo

Nadeem Riaz Nancy Lee Sue Yom Sean McBride Many issues: 1. Neoadj IO- no proven benefit in definitive HPV+ OPC 2. Appears that many failed pts were eligible for ECOG3311 w/o adj RT at all. Why was failure rate so high? TORS approach different? 3. 25Gy/5 fx is not SBRT, but doesn't matter John De Almeida Scott Bratman

Mary Elizabeth (@meharpist) 's Twitter Profile Photo

Why is it that people with malignant glioma's show cognitive decline? A new @nature paper shows that these tumors can grow by modifying brain circuitry, thus taking cognitive function away from their host and ultimately leading to death nature.com/articles/s4158…

Gustavo (@gusviani) 's Twitter Profile Photo

Long-term outcomes from NRG CC001!! ➡️WBRT + meantime +\- HA ➡️Median Fu 12 mo 🗣Continued 👉Preservation of cognitive function 👉Prevention of neurologic symptoms 👉No difference in survival or toxicity #radonc #brainmetastases

Long-term outcomes from NRG CC001!!
➡️WBRT + meantime +\- HA
➡️Median Fu 12 mo
🗣Continued 
👉Preservation of cognitive function     👉Prevention of neurologic symptoms
👉No difference in survival or toxicity
#radonc #brainmetastases
PDBrown (@pdbrownonc) 's Twitter Profile Photo

Final Results CC001 Addition HA to WBRT+memantine · Prevented cognitive failure (HR 0.74,p=0.016) · Less symptom burden 6 & 12 mos · Less symptom interference 6 & 12 mos · Fewer cognitive symptoms overtime · NO diff OS, PFS, Toxicity redjournal.org/article/S0360-…

Final Results CC001
Addition HA to WBRT+memantine
· Prevented cognitive failure (HR 0.74,p=0.016)
· Less symptom burden 6 & 12 mos
· Less symptom interference 6 & 12 mos
· Fewer cognitive symptoms overtime
· NO diff OS, PFS, Toxicity redjournal.org/article/S0360-…
Pierre Blanchard, MD (@pblanchardmd) 's Twitter Profile Photo

Our latest meta-analysis on #chemoradiation in nasopharyngeal cancer out in The Lancet Oncology Huge collaborative work. ✅ 28 trials, 8.000+ pts, 7.6y FU ✅ more chemo (ind+conc or conc+adj) ➡️superior (OS/PFS) to CRT alone but more tox Free 50day link: authors.elsevier.com/a/1hAd45EIIgLp…

Our latest meta-analysis on #chemoradiation in nasopharyngeal cancer out in <a href="/TheLancetOncol/">The Lancet Oncology</a> 

Huge collaborative work. 
✅ 28 trials, 8.000+ pts, 7.6y FU
✅ more chemo (ind+conc or conc+adj) ➡️superior (OS/PFS) to CRT alone but more tox

Free 50day link: authors.elsevier.com/a/1hAd45EIIgLp…
ASTRO (@astro_org) 's Twitter Profile Photo

From the #RedJournal: First prospective evidence of association btwn cerebellar injury and processing speed in brain tumor pts, independent of damage to supratentorial WM. @MSalans @JHGlabed #btsm #ucsdradm bit.ly/salansijrobp

From the #RedJournal: First prospective evidence of association btwn cerebellar injury and processing speed in brain tumor pts, independent of damage to supratentorial WM. @MSalans @JHGlabed #btsm #ucsdradm bit.ly/salansijrobp
arjun sahgal (@sahgalarjun) 's Twitter Profile Photo

Incredible work by PhD student Liam Lawrence Sunnybrook Health Sciences Centre Angus Lau lab showing utility of diffusion sequences on MR-Linac Consortium in prognostication regions within #glioblastoma. Step forward towards personalized dose escalated daily adaptive RT. pubmed.ncbi.nlm.nih.gov/37640160/

Sid Puram, MD PhD (Puram Lab) (@sidpuram) 's Twitter Profile Photo

Thrilled to share our work in Nature Communications describing the ecosystem of vestibular schwannoma. Team effort by Tom Barrett in our lab, Bhuvic Patel, MD in @AlbertHKimMDPhDlab, and many others including Allegra Petti and Craig Buchman @WUSTL_ENT @WashuBTC WashU/BJC Head and Neck Tumor Center at Siteman nature.com/articles/s4146…

Nadeem Riaz (@xrtgenomics) 's Twitter Profile Photo

1/N Finally out!! -- 30Gy for HPV+OPC in Journal of Clinical Oncology – work by the Memorial Sloan Kettering Cancer Center Head and Neck team, led by Nancy Lee, Eric Sherman, and myself on using hypoxia imaging response to cut treatment 60% (70->30Gy)! #radonc #hncsm ascopubs.org/doi/10.1200/JC…

Shuhua (Steve) Zheng (@zheng_shuhua) 's Twitter Profile Photo

Can we use this model GlioPredictor to refine risk classification for LGG patients regarding adjuvant radiation decision? #radonc #glioma

Can we use this model GlioPredictor to refine risk classification for LGG patients regarding adjuvant radiation decision? #radonc #glioma
Akila Viswanathan MD (@anviswanathanmd) 's Twitter Profile Photo

Elsevier Seminars in Radiation Oncology is pleased to share from January's issue "Use of MR-Guided Radiation Therapy for Liver Cancer" by Dr. Sabrina Prime Sabrina Prime, MD , Joshua P. Schiff Joshua Schiff,....Lauren E. Henke Lauren Henke, MD, MSCI. sciencedirect.com/science/articl…

Siteman Cancer Center (@sitemancenter) 's Twitter Profile Photo

Test Account has received a $7.8M grant from the NIH to support a radiation oncology center, co-led by Julie Schwarz and Cliff Robinson – part of a national network of only five centers aimed at understanding the effects of radiation therapy in cancer treatment. bit.ly/4bsT5YX

<a href="/WUSTLmed/">Test Account</a> has received a $7.8M grant from the <a href="/NIH/">NIH</a> to support a radiation oncology center, co-led by <a href="/JulieSchwarz14/">Julie Schwarz</a> and <a href="/SBRT_CR/">Cliff Robinson</a> – part of a national network of only five centers aimed at understanding the effects of radiation therapy in cancer treatment. bit.ly/4bsT5YX
Ethan Damron (@thatdamdoc) 's Twitter Profile Photo

Unfortunately, the Texas Medical Board has delayed approval for my trainee medical permit (PIT) because I took a year off school to get treatment for brain cancer. And now it looks like my residency start date will be delayed. Is there anything that can be done Texas Medical Association ?